B+
Bull case
25%
Probability
Target price
$24.00
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
NRC
NRC HealthDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 confirmed double-digit TRCV growth, positive adjusted profitability, and strong bookings, supporting the possibility of better second-half execution. The release also highlighted ongoing product innovation commercialization.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.6.
What can break
GAAP losses and adjustment-related cash payments may continue to obscure underlying performance.
Momentum
52
Value
52
Sentiment
43
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $21.50 · Bull $24.00 · Bear $16.00Analysis 2026-07-31; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-31 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $26.00
Why
Momentum52 · Δ7d +8.9
Value52 · Δ7d -0.6
Sentiment43 · Δ7d -10.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.6.
Contradictions & invalidation
- • GAAP losses and adjustment-related cash payments may continue to obscure underlying performance.
- • Healthcare-organization demand and execution in the second half remain unverified.
- • GAAP net loss was $3.3 million, operating cash flow was only $1.4 million, and free cash flow was $0.1 million after approximately $2.9 million of adjustment-related cash payments.
Catalyst clock
2026-07-28
Q2 2026 results show recurring-growth strength
Lead driver: Value · See fundamentals
Momentum
52
8% active weight
Current posture
7d trendImproving
Δ7d
+8.9
Δ21d
-19.6
Value
52
47% active weight
Current posture
7d trendFlat
Δ7d
-0.6
Δ21d
-0.8
Sentiment
43
45% active weight
Current posture
7d trendSoftening
Δ7d
-10.9
Δ21d
-17.2
Why this grade
Composite grade D. Momentum 52.0 / Value 52.2 / Sentiment 43.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-31. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$21.50
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$16.00
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$496.58M
Beta
0.50
Shares Out
22.12M
P/E (TTM)
26.3
P/S (TTM)
3.06
P/FCF (TTM)
812.90
Rev YoY
+4.0%
EPS YoY
+1686.9%
Gross Margin
+55.6%
Op Margin
+10.5%
Net Debt
$75.65M
Current Ratio
0.65
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data